Table 4 KEGG assigned differentially expressed proteins between Temple and Murcott mandarin hybrid fruit in metabolic pathways
KEGG pathway | Pathway | Enzyme number |
|---|---|---|
Carbohydrate metabolism | Amino sugar and nucleotide sugar metabolism | ec:2.7.7.9, ec:3.2.1.14, ec:5.1.3.2,ec:5.4.2.2 |
| Â | Ascorbate and aldarate metabolism | ec:1.10.3.3, ec:1.11.1.11, ec:1.6.5.4 |
| Â | Butanoate metabolism | ec:4.1.1.15 |
| Â | Tricarboxylic acid cycle (TCA) | ec:1.1.1.37, ec:1.1.1.42, ec:2.3.1.12, ec:2.3.3.1, ec:4.1.1.49 |
| Â | Fructose and mannose metabolism | ec:2.7.1.11, ec:2.7.1.90, ec:4.1.2.13,ec:5.3.1.1 |
| Â | Galactose metabolism | ec:2.7.1.11, ec:2.7.7.9, ec:5.1.3.2, ec:5.4.2.2 |
| Â | Glycerophospholipid metabolism | ec:3.1.4.4 |
| Â | Glycolysis/Gluconeogenesis | ec:1.2.1.12, ec:2.3.1.12, ec:2.7.1.11, ec:2.7.2.3, ec:4.1.1.1, ec:4.1.1.49, ec:4.1.2.13, ec:5.1.3.3, ec:5.3.1.1, ec:5.4.2.2 |
| Â | Glyoxylate and dicarboxylate metabolism | ec:1.1.1.37, ec:1.11.1.6, ec:2.3.3.1 |
| Â | Pentose and glucuronate interconversions | ec:2.7.7.9, ec:3.1.1.11 |
| Â | Pentose phosphate pathway | ec:1.1.1.49, ec:2.7.1.11, ec:4.1.2.13, ec:5.4.2.2 |
| Â | Pyruvate metabolism | ec:1.1.1.37, ec:2.3.1.12, ec:4.1.1.49, ec:4.4.1.5 |
Amino acid metabolism | Alanine, aspartate and glutamate metabolism | ec:2.6.1.1, ec:2.6.1.2, ec:4.1.1.15 |
| Â | Arginine and proline metabolism | ec:2.6.1.1, ec:3.5.3.1 |
| Â | beta-Alanine metabolism | ec:4.1.1.15 |
| Â | Cysteine and methionine metabolism | ec:2.6.1.1 |
| Â | Glutathione metabolism | ec:1.1.1.42, ec:1.1.1.49, ec:1.11.1.11, ec:1.11.1.12, ec:1.11.1.15, ec:1.11.1.9, ec:2.5.1.18 |
| Â | Phenylalanine metabolism | ec:1.11.1.7,ec:2.6.1.1 |
| Â | Phenylalanine, tyrosine and tryptophan biosynthesis | ec:2.6.1.1 |
| Â | Taurine and hypotaurine metabolism | ec:4.1.1.15 |
| Â | Tryptophan metabolism | ec:1.11.1.6 |
| Â | Tyrosine metabolism | ec:2.6.1.1 |
| Â | Valine, leucine and isoleucine degradation | ec:2.3.1.168 |
Other secondary metabolites | Isoquinoline alkaloid biosynthesis | ec:2.6.1.1 |
| Â | Novobiocin biosynthesis | ec:2.6.1.1 |
| Â | Tropane, piperidine and pyridine alkaloid biosynthesis | ec:1.11.1.6 |
| Â | Streptomycin biosynthesis | ec:5.4.2.2 |
Energy metabolism | Carbon fixation in photosynthetic organisms | ec:1.1.1.37, ec:2.6.1.1, ec:2.6.1.2, ec:2.7.2.3, ec:4.1.1.49, ec:4.1.2.13, ec:5.3.1.1 |
| Â | Carbon fixation pathways in prokaryotes | ec:1.1.1.37, ec:1.1.1.42 |
| Â | Inositol phosphate metabolism | ec:5.3.1.1 |
| Â | Methane metabolism | ec:1.1.1.37, ec:1.11.1.6, ec:1.11.1.7, ec:2.7.1.11, ec:4.1.2.13 |
| Â | Oxidative phosphorylation | ec:3.6.3.6 |
Lipid metabolism | alpha-Linolenic acid metabolism | ec:5.3.99.6 |
| Â | Arachidonic acid metabolism | ec:1.11.1.9 |
| Â | Ether lipid metabolism | ec:3.1.4.4 |
| Â | Primary bile acid biosynthesis | ec:1.3.1.3 |
| Â | Steroid degradation | ec:1.1.1.145 |
| Â | Steroid hormone biosynthesis | ec:1.1.1.145, ec:1.3.1.3 |
Metabolism of terpenoids and polyketides | Terpenoid backbone biosynthesis | ec:5.3.3.2 |
Nucleotide metabolism | Arginine and proline metabolism | ec:3.5.3.11 |
| Â | Cysteine and methionine metabolism | ec:4.4.1.14 |
| Â | Purine metabolism | ec:3.6.1.3, ec:5.4.2.2 |
Xenobiotics biodegradation and metabolism | Chlorocyclohexane and chlorobenzene degradation | ec:3.1.1.45 |
| Â | Drug metabolism - cytochrome P450 | ec:2.5.1.18 |
| Â | Fluorobenzoate degradation | ec:3.1.1.45 |
| Â | Metabolism of xenobiotics by cytochrome P450 | ec:2.5.1.18 |
| Â | Toluene degradation | ec:3.1.1.45 |